Stay updated on Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.

Latest updates to the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded the term Squamous cell carcinoma of the head and neck and included a link to Genetic and Rare Diseases Information Center under resources.SummaryDifference0.2%

- Check24 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0. No user-facing changes to the study details page were detected.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; the content and function of the study page remain unchanged.SummaryDifference0.1%

- Check60 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no clinical content or study details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check75 days agoChange DetectedGlossary display was added to aid understanding of terms in the study record. The update history/footer were revised to show 'Last Update Submitted that Met QC Criteria', display 'No FEAR Act Data', and update the site revision to v3.4.0, replacing the previous labels.SummaryDifference0.2%

Stay in the know with updates to Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.